Thus, given the central role of the IL-6/IL-11–STAT3 pathway in the regulation of breast cancer progression and metastasis, blocking of this pathway by MH may underlie the latter’s multi-faceted effects that are reported in this study. The gene discussed is IL11; the disease is breast cancer.